Decreasing Late Mortality Among Five-Year Survivors of Cancer in Childhood and Adolescence: A Population-Based Study in the Nordic Countries
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
PURPOSE: To assess the risk of death in patients who survive more than 5 years after diagnosis of childhood cancer and to evaluate causes of death in fatal cases. PATIENTS AND METHODS: This was a population-based study in the five Nordic countries (Denmark, Finland, Iceland, Norway, and Sweden) using data of the nationwide cancer registries and the cause-of-death registries. The study cohort included 13,711 patients who were diagnosed with cancer before the age of 20 years between 1960 and 1989 and who survived at least 5 years from diagnosis. By December 31, 1995, 1,422 patients had died, and death certificates were assessed in 1,402. Standardized mortality ratios (SMRs) for validated causes of death were calculated based on 156,046 patient-years at risk. RESULTS: The overall SMR was 10.8 (95% confidence interval [CI], 10.3 to 11.5), mainly due to high excess mortality from the primary cancer. SMR for second cancer was 4.9 (95% CI, 3.9 to 5.9) and was 3.1 (95% CI, 2.8 to 3.5) for noncancer death. The pattern of causes of death varied markedly between different groups of primary cancer diagnoses and was highly dependent on time passed since diagnosis. Overall late mortality was significantly lower in patients treated during the most recent period of time, 1980 to 1989, compared with those treated from 1960 to 1979 (hazard ratio, 0.61; 95% CI, 0.54 to 0.70), and there was no increase in rates of death due to cancer treatment. CONCLUSION: Long-term survivors of childhood cancer had an increased mortality rate, mainly dying from primary cancers. However, modern treatments have reduced late cancer mortality without increasing the rate of therapy-related deaths.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
The Statistical Analysis of Failure Time Data.
Aitkin, M., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,877
Cancer Survival Corrected for Heterogeneity in Patient Withdrawal
Hakulinen, T. (1982) · Biometrics · doi:10.2307/2529873 · Cited by 453
A classification scheme for childhood cancer
Birch, J. M., & Marsden, H. B. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910400508 · Cited by 258
Sankila, R., Garwicz, S., Olsen, J. H., Döllner, H., Hertz, H., Kreuger, A., Langmark, F., Lanning, M., Möller, T., & Tulinius, H. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.5.1442 · Cited by 221
Self-citationPrograms for adult survivors of childhood cancer.
Oeffinger, K. C., Eshelman, D. A., Tomlinson, G. E., & Buchanan, G. R. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2864 · Cited by 141
Gustafsson, G., Kreuger, A., Clausen, N., Garwicz, S., Kristinsson, J., Lie, S. O., Pj, M., Perkkiö, M. V., YSSING, M., Saarinen‐Pihkala, U., et al. (1998) · Acta Paediatrica · doi:10.1111/j.1651-2227.1998.tb00923.x · Cited by 124
Self-citationGreen, D. M., Hyland, A., Chung, C. S., Zevon, M. A., & Hall, B. C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3207 · Cited by 122
Late mortality of long-term survivors of childhood cancer.
Hudson, M. M., Jones, D., Boyett, J. M., Sharp, G. B., & Pui, C. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2205 · Cited by 118
Late deaths and survival after childhood cancer: implications for cure
Robertson, C. M., Hawkins, M. M., & Kingston, J. E. (1994) · BMJ · doi:10.1136/bmj.309.6948.162 · Cited by 113
Cited by
Armstrong, G. T., Liu, Q., Yasui, Y., Neglia, J. P., Leisenring, W., Robison, L. L., & Mertens, A. C. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.1425 · Cited by 776
“One important exception, however, is a population-based study from five Nordic countries (Denmark, Finland, Iceland, Norway, and Sweden) that identified 13,711 survivors diagnosed between 1960 and 1989 before the age of 20.(34) Many of their findings confirm what the CCSS has identified among survivors in the United S…”
BackgroundMertens, A. C., Liu, Q., Neglia, J. P., Wasilewski, K., Leisenring, W., Armstrong, G. T., Robison, L. L., & Yasui, Y. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn310 · Cited by 730
Lipshultz, S. E., Lipsitz, S. R., Sallan, S. E., Dalton, V. M., Mone, S. M., Gelber, R. D., & Colan, S. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.121 · Cited by 727
Lipshultz, S. E., Rifai, N., Dalton, V. M., Levy, D. E., Silverman, L. B., Lipsitz, S. R., Colan, S. D., Asselin, B. L., Barr, R. D., Clavell, L. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035153 · Cited by 623
Lipshultz, S. E., Adams, M. J., Colan, S. D., Constine, L. S., Herman, E. H., Hsu, D. T., Hudson, M. M., Kremer, L. C., Landy, D. C., Miller, T. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e3182a88099 · Cited by 612
Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer
Armstrong, G. T., Chen, Y., Yasui, Y., Leisenring, W., Gibson, T. M., Mertens, A. C., Stovall, M., Oeffinger, K. C., Bhatia, S., Krull, K. R., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1510795 · Cited by 568
Cardiovascular Disease After Hodgkin Lymphoma Treatment: 40-Year Disease Risk
van Nimwegen, F. A., Schaapveld, M., Janus, C. P. M., Krol, A. D. G., Petersen, E. J., Raemaekers, J. M. M., Kok, W. E. M., Aleman, B. M. P., & van Leeuwen, F. E. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.1180 · Cited by 514
Anthracycline Cardiotoxicity: From Bench to Bedside
Gianni, L., Herman, E. H., Lipshultz, S. E., Minotti, G., Sarvazyan, N., & Sawyer, D. B. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.9401 · Cited by 454
Wouters, K. A., Kremer, L. C. M., Miller, T. L., Herman, E. H., & Lipshultz, S. E. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05759.x · Cited by 453
Role of Cancer Treatment in Long-Term Overall and Cardiovascular Mortality After Childhood Cancer
Tukenova, M., Guibout, C., Oberlin, O., Doyon, F., Mousannif, A., Haddy, N., Guérin, S., Pacquement, H., Aouba, A., Hawkins, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.2267 · Cited by 451
Long-term Cause-Specific Mortality Among Survivors of Childhood Cancer
Reulen, R. C. (2010) · JAMA · doi:10.1001/jama.2010.923 · Cited by 447
Lipshultz, S. E., Scully, R. E., Lipsitz, S. R., Sallan, S. E., Silverman, L. B., Miller, T. L., Barry, E. V., Asselin, B. L., Athale, U., Clavell, L. A., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70204-7 · Cited by 446
de Ferranti, S. D., Steinberger, J., Ameduri, R., Baker, A., Gooding, H., Kelly, A. S., Mietus-Snyder, M., Mitsnefes, M. M., Peterson, A. L., St-Pierre, J., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000618 · Cited by 441
Nathan, P. C., Greenberg, M. L., Ness, K. K., Hudson, M. M., Mertens, A. C., Mahoney, M. C., Gurney, J. G., Donaldson, S. S., Leisenring, W. M., Robison, L. L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.9607 · Cited by 425
Mody, R., Li, S., Dover, D. C., Sallan, S., Leisenring, W., Oeffinger, K. C., Yasui, Y., Robison, L. L., & Neglia, J. P. (2008) · Blood · doi:10.1182/blood-2007-10-117150 · Cited by 387
Anthracycline associated cardiotoxicity in survivors of childhood cancer
Lipshultz, S. E., Alvarez, J. A., & Scully, R. E. (2008) · Heart · doi:10.1136/hrt.2007.136093 · Cited by 379
Life Expectancy in Patients Surviving More Than 5 Years After Hematopoietic Cell Transplantation
Martin, P. J., Counts, G. W., Appelbaum, F. R., Lee, S. J., Sanders, J. E., Deeg, H. J., Flowers, M. E. D., Syrjala, K. L., Hansen, J. A., Storb, R. F., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.6693 · Cited by 366
Health status of adolescent and young adult cancer survivors
Tai, E., Buchanan, N., Townsend, J., Fairley, T., Moore, A., & Richardson, L. C. (2012) · Cancer · doi:10.1002/cncr.27445 · Cited by 327
High Risk of Symptomatic Cardiac Events in Childhood Cancer Survivors
van der Pal, H. J., van Dalen, E. C., van Delden, E., van Dijk, I. W., Kok, W. E., Geskus, R. B., Sieswerda, E., Oldenburger, F., Koning, C. C., van Leeuwen, F. E., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.4730 · Cited by 320
Childhood Cancer Survival Trends in Europe: A EUROCARE Working Group Study
Gatta, G., Capocaccia, R., Stiller, C., Kaatsch, P., Berrino, F., Terenziani, M., & the EUROCARE Working Group (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.554 · Cited by 315
Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management
Barry, E., Alvarez, J. A., Scully, R. E., Miller, T. L., & Lipshultz, S. E. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.8.1039 · Cited by 307
Singhal, A., Ross, J., Seminog, O., Hawton, K., & Goldacre, M. J. (2014) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814522033 · Cited by 289
“Previous studies in adults have shown an increased risk of suicide and attempted suicide in patients with cancer,(18) while other studies on children and adolescents have not found an increased risk of suicide.(19) Table 4.”
ResultDoxorubicin‐Induced Cardiomyopathy in Children
Mancilla, T. R., Iskra, B., & Aune, G. J. (2019) · Comprehensive Physiology · doi:10.1002/cphy.c180017 · Cited by 108
Late Effects in Long-Term Survivors After Treatment for Childhood Acute Leukemia
Haddy, T. B., Mosher, R. B., & Reaman, G. H. (2009) · Clinical Pediatrics · doi:10.1177/0009922809332680 · Cited by 82
Ceschel, S., Casotto, V., Valsecchi, M. G., Tamaro, P., Jankovic, M., Hanau, G., Fossati, F., Pillon, M., Rondelli, R., Sandri, A., et al. (2006) · Pediatric Blood & Cancer · doi:10.1002/pbc.20726 · Cited by 44
“[15] found an improvement of longterm prognosis over time, with mortality after 5 years significantly lower in patients treated after 1980 than before.”
BackgroundHecker-Nolting, S., Langer, T., Blattmann, C., Kager, L., & Bielack, S. S. (2021) · Cancer Management and Research · doi:10.2147/cmar.s287908 · Cited by 10
“nancies have been reported as being the most frequent cause of late death after the original malignancy.(5) In one”
Background
Metadata
- Authors
- Möller, T. R., Garwicz, S., Barlow, L., Winther, J. F., Glattre, E., Olafsdottir, G., Olsen, J. H., Perfekt, R., Ritvanen, A., Sankila, R., Tulinius, H., & for the Association of the Nordic Cancer Registries and the Nordic Society for Pediatric Hematology and Oncology
- Venue
- Journal of Clinical Oncology
- Published
- 2001-07-01
- Volume
- 19
- Issue
- 13
- Pages
- 3173-3181
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1894979576
- Cited by
- 259
- References
- 14
- FWCI
- 9.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.